Metabolic driver of Parkinson’s offers new target for treatment
, 2025-04-24 09:17:00 Researchers have identified a key enzyme driving forms of Parkinson’s, and have shown how blocking it restores normal function in animal and cell models – offering a promising new drug target for the condition. In Parkinson’s, a protein known as alpha-synuclein builds up in clumps called Lewy bodies in nerve cells in…